CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 175 filers reported holding CLOVIS ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $21,000 | -38.2% | 7,578 | 0.0% | 0.00% | – |
| Q3 2021 | $34,000 | -22.7% | 7,578 | 0.0% | 0.00% | – |
| Q2 2021 | $44,000 | -17.0% | 7,578 | 0.0% | 0.00% | – |
| Q1 2021 | $53,000 | +47.2% | 7,578 | 0.0% | 0.00% | – |
| Q4 2020 | $36,000 | -18.2% | 7,578 | 0.0% | 0.00% | – |
| Q3 2020 | $44,000 | -13.7% | 7,578 | 0.0% | 0.00% | – |
| Q2 2020 | $51,000 | +6.2% | 7,578 | 0.0% | 0.00% | – |
| Q1 2020 | $48,000 | -39.2% | 7,578 | 0.0% | 0.00% | – |
| Q4 2019 | $79,000 | +163.3% | 7,578 | 0.0% | 0.00% | – |
| Q3 2019 | $30,000 | -73.5% | 7,578 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $113,000 | -39.9% | 7,578 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $188,000 | +38.2% | 7,578 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $136,000 | -39.0% | 7,578 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $223,000 | -35.4% | 7,578 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $345,000 | -13.8% | 7,578 | 0.0% | 0.00% | -33.3% |
| Q1 2018 | $400,000 | -22.3% | 7,578 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $515,000 | -17.5% | 7,578 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $624,000 | -12.1% | 7,578 | 0.0% | 0.00% | -20.0% |
| Q2 2017 | $710,000 | +47.3% | 7,578 | 0.0% | 0.01% | +25.0% |
| Q1 2017 | $482,000 | +43.0% | 7,578 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $337,000 | +23.4% | 7,578 | 0.0% | 0.00% | +50.0% |
| Q3 2016 | $273,000 | +162.5% | 7,578 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $104,000 | -28.3% | 7,578 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $145,000 | -11.6% | 7,578 | +61.5% | 0.00% | 0.0% |
| Q4 2015 | $164,000 | -61.9% | 4,692 | 0.0% | 0.00% | -75.0% |
| Q3 2015 | $431,000 | +4.6% | 4,692 | 0.0% | 0.00% | +33.3% |
| Q2 2015 | $412,000 | +18.4% | 4,692 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $348,000 | +32.3% | 4,692 | 0.0% | 0.00% | +50.0% |
| Q4 2014 | $263,000 | – | 4,692 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |